MoneyWorks4Me

Senores Pharmaceuticals informs about disclosure

05 Dec 2025 Evaluate

Senores Pharmaceuticals has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 04, 2025 for Renosen Pharmaceuticals.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..